HR 5160·Federal·house
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Floor Vote ScheduledFiled Sep 4, 2025
Sponsor: Rep. Smith, Christopher H. [R-NJ-4] (R)
Latest Action
Motion to reconsider laid on the table Agreed to without objection.
Jul 20, 2026
Summary
The bill renews the Stem Cell Therapeutic and Research Act of 2005, keeping the C.W. Bill Young Cell Transplantation Program funded at $31 million for the current year and raising it to $33 million each year from 2027 to 2031. It also moves the deadline for the national cord‑blood inventory from 2026 to 2031, impacting researchers, clinicians and patients who depend on stem‑cell therapies.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HR 5160 changes status, plus AI-powered summaries and stage predictions.
Sign up free